Treatment for Secondary Hypogonadism in Male Teenagers

Initial Diagnostic Confirmation

The European Association of Urology recommends confirming the diagnosis of secondary hypogonadism with morning total testosterone measurements on two separate occasions, with levels <300 ng/dL indicating hypogonadism, and measuring LH and FSH levels to confirm secondary hypogonadism 1, 2
Assessing for reversible causes such as obesity, medications affecting the hypothalamic-pituitary axis, metabolic disorders, and pituitary/hypothalamic pathology is crucial in the diagnosis of secondary hypogonadism 1, 3

The European Urology guidelines suggest that gonadotropin therapy is mandatory and testosterone is absolutely contraindicated when fertility preservation is important in male teenagers with secondary hypogonadism 1, 2
Starting with hCG to stimulate endogenous testosterone production and testicular growth, and adding FSH for combined therapy, provides optimal outcomes for spermatogenesis 1

Weight loss through low-calorie diets can reverse obesity-associated secondary hypogonadism, with a modest expected testosterone increase of 1-2 nmol/L 1, 3
Combining lifestyle changes with hormonal therapy yields better outcomes in symptomatic patients 1, 3

The European Urology guidelines recommend checking testosterone levels at 2-3 months after initiation or dose changes, and monitoring hematocrit periodically, withholding treatment if >54% 1, 2
Assessing for symptoms improvement, such as libido, erectile function, energy, and secondary sexual characteristics, is essential during treatment 1, 2

The European Association of Urology strongly recommends against testosterone therapy in individuals pursuing fertility, and in those with active or treated male breast cancer, or severe untreated obstructive sleep apnea 1, 2

Testosterone therapy can improve sexual function and libido, develop/maintain secondary sexual characteristics, increase muscle mass and bone density, and provide small improvements in quality of life 1, 2, 3
Gonadotropin therapy can stimulate endogenous testosterone production, promote testicular growth and spermatogenesis, and preserve future fertility potential 1